Health ❯ Healthcare

Drug Efficacy

Clinical Research Weight Loss Drugs Progression-Free Survival Statins Patient Outcomes Statistical Significance Therapeutic Potential Clinical Outcomes Weight Loss Treatments Comparative Effectiveness Monoclonal Antibodies Clinical Study Results Blood Sugar Control

Upstream Bio Sets Phase 3 Start for Verekitug in Severe Asthma and Nasal Polyps

The move signals a pivot to pivotal trials based on Phase 2 gains with funding in place through 2027.

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

Epcoritamab Added to R2 Yields Large Efficacy Gains in Relapsed Follicular Lymphoma

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing

Regeneron’s Garetosmab Slashes New Bone Lesions in FOP Phase 3, U.S. Filing Planned This Year

Sanofi’s Amlitelimab Meets Phase 3 Goals in Eczema as Shares Fall on Tepid Efficacy